(Q36637647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

Krzysztof Giannopoulos

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Michael Schmitt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

1 reference

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2028-2036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

Chronic lymphocytic leukemia (CLL): first-line treatment

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Chronic lymphocytic leukemia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Infection and immunity in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Abnormal T-cell function in B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Immune defects in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Mdm2 in growth signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

p53-independent activities of MDM2 and their relevance to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Universal tumor antigens as targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

A phase I/II trial of oxidized autologous tumor vaccines during the "watch and wait" phase of chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600709721

10.1080/10428190600709721

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17071473%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference